In this month’s issue
February 2022
Michael Sassano: GMP Article No 9: Bringing New Products to GMP Facility
Now that your GMP facility has been opened, it’s time to add some new products to your new facility. Luckily, …
Read More
Read More
Janet E Jackim, Zuber Lawler LLP: The Arizona Medical & Adult Use Marijuana Programs
Within certain limits, Arizona confers legal immunity from criminal prosecution for the cultivation, manufacture, distribution, sale, possession, and use of …
Read More
Read More
Robert Thomas: The Cost of Expanding the Panel of Elemental Contaminants in Cannabis and Hemp Consumer Products by ICP-MS
Imagine you run a cannabis testing lab and have been asked to look at an expanded panel of elemental contaminants …
Read More
Read More
Green Light Law Group: OLCC Finalizes New Rules on Delta-8 THC and other Artificially Derived Cannabinoids
The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as …
Read More
Read More
Frankfurt Kurnit Klein & Selz: Court Finds Implied License Allowed Cannabis Brand To Use Advertising Materials Created By Freelancer
Defendant Pure Spectrum CBD is a cannabis company that (according to its website) was “born in the mountains of Evergreen, Colorado” and …
Read More
Read More
Latham-London: Cannabis Rethink Sparks PE Interest
In years gone by, the prospect of significant PE investment in the cannabis industry would have been unthinkable for many …
Read More
Read More
Lewis Brisbois Bisgaard & Smith LLP: CDC Issues Best Practices For Fleet Marijuana Policies
The CDC recently issued guidance to businesses developing marijuana policies, balancing state legalization efforts and fleet safety. Per the CDC, …
Read More
Read More
Green Light Law Group: New York and Washington Legislatures Consider Legalizing Psilocybin
Legislators in New York and Washington state recently introduced bills to legalize psilocybin services. While Washington’s proposed legislation tracks Oregon’s …